Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Harbeck

Showing results (81-90 of 585) with videos related to

Pageof 59
Sort By:
Critical Reviews in Clinical Laboratory Sciences|March 17, 2007
Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithmsNadia Harbeck, Manfred Schmitt, Stefan Paepke, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 9, 2019
CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and AbemaciclibTanja K Eggersmann, Tom Degenhardt, Oleg Gluz, et al.
Future Oncology (London, England)|March 6, 2019
Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studiesNadia Harbeck, Jessie Wang, Gordon Philipp Otto, et al.
Reviews in Obstetrics & Gynecology|June 13, 2014
Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast CancerAlex Farr, Rachel Wuerstlein, Annika Heiduschka, et al.
JMIR Cardio|September 11, 2023
Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development StudyKristina Klier, Yash J Patel, Timo Schinköthe, et al.
MMW Fortschritte Der Medizin|May 28, 2026
[Innovative treatment approaches for early-stage breast cancer]Julia Caroline Michaeli, Friederike Hagemann, Alexandra Stefan, et al.
International Journal of Molecular Sciences|June 21, 2017
Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic PatientsXi Zhang, Simone Hofmann, Brigitte Rack, et al.
Breast Care (Basel, Switzerland)|February 20, 2014
Genomic profiling in luminal breast cancerOleg Gluz, Daniel Hofmann, Rachel Würstlein, et al.
Breast Care (Basel, Switzerland)|January 15, 2021
European Breast Cancer Conference 12, October 2-3, 2020: Interview with the ChairsRachel Wuerstlein, Nadia Harbeck, Tanja Spanic, et al.
The Oncologist|January 11, 2018
Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III StudiesNadia Harbeck, Pere Gascón, Andriy Krendyukov, et al.
Pageof 59

Showing results (81-90 of 585) with videos related to

Sort By:
Pageof 59
Critical Reviews in Clinical Laboratory Sciences|March 17, 2007
Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithmsNadia Harbeck, Manfred Schmitt, Stefan Paepke, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 9, 2019
CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and AbemaciclibTanja K Eggersmann, Tom Degenhardt, Oleg Gluz, et al.
Future Oncology (London, England)|March 6, 2019
Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studiesNadia Harbeck, Jessie Wang, Gordon Philipp Otto, et al.
Reviews in Obstetrics & Gynecology|June 13, 2014
Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast CancerAlex Farr, Rachel Wuerstlein, Annika Heiduschka, et al.
JMIR Cardio|September 11, 2023
Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development StudyKristina Klier, Yash J Patel, Timo Schinköthe, et al.
MMW Fortschritte Der Medizin|May 28, 2026
[Innovative treatment approaches for early-stage breast cancer]Julia Caroline Michaeli, Friederike Hagemann, Alexandra Stefan, et al.
International Journal of Molecular Sciences|June 21, 2017
Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic PatientsXi Zhang, Simone Hofmann, Brigitte Rack, et al.
Breast Care (Basel, Switzerland)|February 20, 2014
Genomic profiling in luminal breast cancerOleg Gluz, Daniel Hofmann, Rachel Würstlein, et al.
Breast Care (Basel, Switzerland)|January 15, 2021
European Breast Cancer Conference 12, October 2-3, 2020: Interview with the ChairsRachel Wuerstlein, Nadia Harbeck, Tanja Spanic, et al.
The Oncologist|January 11, 2018
Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III StudiesNadia Harbeck, Pere Gascón, Andriy Krendyukov, et al.
Pageof 59